ReviewCurrent topics in medicinal chemistry2026
Advances in Cervical Cancer Diagnostics Based on Immunosensors: Innovative Approaches and Tumor Biomarkers.
Review in Current topics in medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Therapies Applied to Biological Barriers: From Overcoming to Tissue Regeneration.Current topics in medicinal chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Immunosensors are promising analytical tools for screening and diagnosis of cervical cancer (CC) due to being practical, rapid and economical as compared with conventional methods. Choosing a sensible and specific tumor marker (TM) serving as target which is immobilized on sensor surface is a crucial step for a CC immunosensor. In addition, the transducer design involving optical, piezoelectric or electrochemical converting of antigen-antibody interaction in the analytical signals could be projected to achieve a maximal sensitivity, guarantying accuracy in the detection of CC. This review aims to describes mostly important TMs and transducers used for development of immunosensors for CC. An overview of experimental articles published in the last decade designed to detect TM associated with CC, using optical, electrochemical and piezoelectric transductions mode are discussed. Although serological TM, such as SCCa, CEA and CA125 are still predominantly used, new biomarkers including the P16, MCM5 and PP1γ2 have been considered specific and reliable for CC diagnostic. Recently, new strategies such as multiplex assays and samples obtained directly from tumor tissue, as well self-sampling, have been proposed to overcome several limitations. Optical and electrochemical are the most popular transducers, and nanoparticles as electrochemical probes and sandwich assays have been the strategies for increasing the limit of detection and sensitivity of immunosensors for CC diagnostic.
Indexed as
Identifiers
40192049What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.